Document Detail


Pulmonary hypertension in COPD.
MedLine Citation:
PMID:  18978137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mild-to-moderate pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD); such a complication is associated with increased risks of exacerbation and decreased survival. Pulmonary hypertension usually worsens during exercise, sleep and exacerbation. Pulmonary vascular remodelling in COPD is the main cause of increase in pulmonary artery pressure and is thought to result from the combined effects of hypoxia, inflammation and loss of capillaries in severe emphysema. A small proportion of COPD patients may present with "out-of-proportion" pulmonary hypertension, defined by a mean pulmonary artery pressure >35-40 mmHg (normal is no more than 20 mmHg) and a relatively preserved lung function (with low to normal arterial carbon dioxide tension) that cannot explain prominent dyspnoea and fatigue. The prevalence of out-of-proportion pulmonary hypertension in COPD is estimated to be very close to the prevalence of idiopathic pulmonary arterial hypertension. Cor pulmonale, defined as right ventricular hypertrophy and dilatation secondary to pulmonary hypertension caused by respiratory disorders, is common. More studies are needed to define the contribution of cor pulmonale to decreased exercise capacity in COPD. These studies should include improved imaging techniques and biomarkers, such as the B-type natriuretic peptide and exercise testing protocols with gas exchange measurements. The effects of drugs used in pulmonary arterial hypertension should be tested in chronic obstructive pulmonary disease patients with severe pulmonary hypertension. In the meantime, the treatment of cor pulmonale in chronic obstructive pulmonary disease continues to rest on supplemental oxygen and a variety of measures aimed at the relief of airway obstruction.
Authors:
A Chaouat; R Naeije; E Weitzenblum
Related Documents :
8921647 - Caution with use of cimetidine in tolazoline induced upper gastrointestinal bleeding.
3843427 - Severe cardiac dysrhythmia from barium acetate ingestion.
24441437 - Endovascular reconstruction of an interrupted inferior vena cava.
20956167 - Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: path...
3156887 - Reversible optic neuropathy due to carotid-cavernous fistula.
690677 - Pulmonary edema following fatal aneurysm rupture.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The European respiratory journal     Volume:  32     ISSN:  1399-3003     ISO Abbreviation:  Eur. Respir. J.     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-03     Completed Date:  2009-05-08     Revised Date:  2013-05-23    
Medline Journal Info:
Nlm Unique ID:  8803460     Medline TA:  Eur Respir J     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1371-85     Citation Subset:  IM    
Affiliation:
Dept for Respiratory Diseases and Respiratory Intensive Care, Centre Hospitalier Universitaire de Nancy, Vandoeuvre-les-Nancy, France. a.chaouat@chu-nancy.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anoxia
Biological Markers / metabolism
Disease Progression
Emphysema / complications,  diagnosis
Humans
Hypertension, Pulmonary / complications*
Lung / pathology
Lung Transplantation
Natriuretic Peptide, Brain / metabolism
Oxygen / metabolism
Prognosis
Pulmonary Disease, Chronic Obstructive / complications*
Pulmonary Gas Exchange
Pulmonary Medicine / methods
Sleep
Chemical
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protozoa in respiratory pathology: a review.
Next Document:  Carotid body oxygen sensing.